Proposed Information Collection Activity; Comment Request, 1998-1999 [07-127]
Download as PDF
<![CDATA[
1998
Federal Register / Vol. 72, No. 10 / Wednesday, January 17, 2007 / Notices
desist from the aforementioned alleged
violations of the Act; (b) order PANYNJ
to pay reparations for any violations of
the Act plus interest, costs, attorney’s
fees, and any other damages to be
determined; (c) command PANYNJ to
comply with all applicable provisions of
the Agreement; and (d) any other relief
as the Commission determines to be
proper, fair, and just.
This proceeding has been assigned to
the Office of Administrative Law Judges.
Hearing in this matter, if any is held,
shall commence within the time
limitations prescribed in 46 CFR 502.61,
and only after consideration has been
given by the parties and the presiding
officer to the use of alternative forms of
dispute resolution. The hearing shall
include oral testimony and crossexamination in the discretion of the
presiding officer only upon proper
showing that there are genuine issues of
material fact that cannot be resolved on
the basis of sworn statements, affidavits,
depositions, or other documents or that
the nature of the matter in issue is such
that an oral hearing and crossexamination are necessary for the
development of an adequate record.
Pursuant to the further terms of 46 CFR
502.61, the initial decision of the
presiding officer in this proceeding shall
be issued by January 8, 2008, and the
final decision of the Commission shall
be issued by May 7, 2008.
Bryant L. VanBrakle,
Secretary.
[FR Doc. E7–496 Filed 1–16–07; 8:45 am]
BILLING CODE 6730–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
mstockstill on PROD1PC61 with NOTICES
AGENCY:
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (DHHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting.
The meeting is open to the public.
DATES: The meeting will be held on
February 5, 2007, from 9 a.m. to 5 p.m.,
and on February 6, 2007, from 9 a.m. to
12 p.m.
ADDRESSES: Department of Health and
Human Services; Hubert H. Humphrey
Building, Room 800; 200 Independence
Avenue, SW., Washington, DC 20201.
VerDate Aug<31>2005
13:58 Jan 16, 2007
Jkt 211001
Ms.
Emma English, Program Analyst,
National Vaccine Program Office,
Department of Health and Human
Services, Room 443–H Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201;
(202) 690–5566, nvpo@hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Pursuant
to Section 2101 of the Public Service
Act (42 U.S.C. 300aa–1), the Secretary of
Health and Human Services was
mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The National
Vaccine Advisory Committee was
established to provide advice and make
recommendations to the Assistant
Secretary for Health, as the Director of
the National Vaccine Program, on
matters related to the program’s
responsibilities.
Topics to be discussed at the meeting
include the 2006–2007 influenza
season, Departmental vaccine priorities,
adolescent and adult immunization,
immunization registry systems, and the
Pandemic and All-Hazards
Preparedness Act. Subcommittee
meetings will be held on the morning of
February 6, 2007. A tentative agenda is
currently available on the NVAC Web
site: https://www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is
limited to space available. Individuals
must provide a photo ID for entry into
the Humphrey Building. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Members of
the public will have the opportunity to
provide comments at the meeting.
Public comment will be limited to five
minutes per speaker. Any members of
the public who wish to have printed
material distributed to NVAC members
should submit materials to the
Executive Secretary, NVAC, through the
contact person listed above prior to
close of business January 31, 2007. Preregistration is required for both public
attendance and comment. Any
individual who wishes to attend the
meeting and/or participate in the public
comment session should e-mail
nvpo@hhs.gov or call 202–690–5566.
SUPPLEMENTARY INFORMATION:
Dated: January 11, 2007.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E7–553 Filed 1–16–07; 8:45 am]
BILLING CODE 4150–44–P
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Childhood
Agricultural Safety and Health
Research, Request for Applications
(RFA) OH–07–002
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 8 a.m.–5 p.m., February 6,
2007 (Closed).
Place: Residence Inn Marriott, 1456 Duke
Street, Alexandria, Virginia 22314.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to RFA OH–07–002, ‘‘Childhood
Agricultural Safety and Health Research.’’
Contact Person for More Information: Steve
Olenchock, Scientific Review Administrator,
National Institute for Occupational Safety
and Health, 1095 Willowdale Road,
Morgantown, WV 26506, telephone (304)
285–6271.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–506 Filed 1–16–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Uniform Project Description
(UPD) Program Narrative for
Discretionary Grant Application Form
OMB No. 0970–0139.
Description: The Administration for
Children and Families (ACF) has more
E:\FR\FM\17JAN1.SGM
17JAN1
Federal Register / Vol. 72, No. 10 / Wednesday, January 17, 2007 / Notices
than 40 discretionary grant programs.
The proposed information collection
form would be a uniform discretionary
application form eligible for use by
grant applications to submit project
information in response to ACF program
announcements. ACF would use this
information, along with other OMBapproved information collections, to
evaluate and rank applicants and
protect the integrity of the grantee
selection process. All ACF discretionary
grant programs would be eligible but not
required to use this application form.
The application consists of general
information and instructions; the
Standard Form 424 series that requests
basic information, budget information,
budget information and assurances; the
Project Description requesting the
1999
applicant to describe how these
objectives will be achieved; along with
assurances and certifications. Guidance
for the content of information requested
in the Project Description is found in
OMB Circulars A–102 and A–110.
Respondents: Applicants for ACF
Discretionary Grant Programs.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average burden
hours per
response
Total burden
hours
UPD .................................................................................................................
mstockstill on PROD1PC61 with NOTICES
Instrument
11,960
1
40
478,400
Estimated Total Annual Burden
Hours: 478,400.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: January 11, 2007.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 07–127 Filed 1–16–07; 8:45 am]
BILLING CODE 4184–01–M
VerDate Aug<31>2005
13:58 Jan 16, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006D–0514]
Draft Guidance for Industry: Minimally
Manipulated, Unrelated, Allogeneic
Placental/Umbilical Cord Blood
Intended for Hematopoietic
Reconstitution in Patients with
Hematological Malignancies;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a draft document entitled
‘‘Guidance for Industry: Minimally
Manipulated, Unrelated, Allogeneic
Placental/Umbilical Cord Blood
Intended for Hematopoietic
Reconstitution in Patients with
Hematological Malignancies’’ dated
December 2006. The draft guidance
document provides recommendations
that would allow the manufacturer,
generally a cord blood bank, to apply for
licensure of minimally manipulated,
unrelated, allogeneic placental/
umbilical cord blood, for specified
indications. The document also contains
information about the manufacture of
minimally manipulated, unrelated,
allogeneic placental/umbilical cord
blood and how to comply with
applicable regulatory requirements.
DATES: Submit written or electronic
comments on the draft guidance by
April 17, 2007 to ensure their adequate
consideration in preparation of the final
guidance. General comments on agency
guidance documents are welcome at any
time.
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Submit written requests for
single copies of the draft guidance to the
Office of Communication, Training, and
Manufacturers Assistance (HFM–40),
Center for Biologics Evaluation and
Research (CBER), Food and Drug
Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852–1448.
Send one self-addressed adhesive label
to assist the office in processing your
requests. The draft guidance may also be
obtained by mail by calling CBER at 1–
800–835–4709 or 301–827–1800. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance document.
Submit written comments on the draft
guidance to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT:
Kathleen E. Swisher, Center for
Biologics Evaluation and Research
(HFM–17), Food and Drug
Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852–1448,
301–827–6210.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Background
FDA is announcing the availability of
a draft document entitled ‘‘Guidance for
Industry: Minimally Manipulated,
Unrelated, Allogeneic Placental/
Umbilical Cord Blood Intended for
Hematopoietic Reconstitution in
Patients with Hematological
Malignancies’’ dated December 2006.
The draft guidance document provides
recommendations that would allow the
manufacturer, generally a cord blood
bank, to apply for licensure of
minimally manipulated, unrelated,
allogeneic placental/umbilical cord
blood, for specified indications. The
E:\FR\FM\17JAN1.SGM
17JAN1
]]>Agencies
[Federal Register Volume 72, Number 10 (Wednesday, January 17, 2007)]
[Notices]
[Pages 1998-1999]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-127]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Proposed Projects
Title: Uniform Project Description (UPD) Program Narrative for
Discretionary Grant Application Form
OMB No. 0970-0139.
Description: The Administration for Children and Families (ACF) has
more
[[Page 1999]]
than 40 discretionary grant programs. The proposed information
collection form would be a uniform discretionary application form
eligible for use by grant applications to submit project information in
response to ACF program announcements. ACF would use this information,
along with other OMB-approved information collections, to evaluate and
rank applicants and protect the integrity of the grantee selection
process. All ACF discretionary grant programs would be eligible but not
required to use this application form. The application consists of
general information and instructions; the Standard Form 424 series that
requests basic information, budget information, budget information and
assurances; the Project Description requesting the applicant to
describe how these objectives will be achieved; along with assurances
and certifications. Guidance for the content of information requested
in the Project Description is found in OMB Circulars A-102 and A-110.
Respondents: Applicants for ACF Discretionary Grant Programs.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
UPD......................................... 11,960 1 40 478,400
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 478,400.
In compliance with the requirements of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Administration, Office of Information Services, 370 L'Enfant Promenade,
SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail
address: infocollection@acf.hhs.gov. All requests should be identified
by the title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Dated: January 11, 2007.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 07-127 Filed 1-16-07; 8:45 am]
BILLING CODE 4184-01-M
